| Literature DB >> 35273829 |
Hui Xiong1, Yu Xi1, Zhiwei Yuan1, Boyu Wang1, Shaojie Hu1, Can Fang1, Yixin Cai1, Xiangning Fu1, Lequn Li1.
Abstract
Stimulator of interferon genes (STING) pathway activation predicts the effectiveness of targeting the PD-1/PD-L1 axis in lung cancer. Active IFN-γ signaling is a common feature in tumors that respond to PD-1/PD-L1 blockade. The connection between IFN-γ and STING signaling in cancer cells has not been documented. We showed that IFN-γ caused DNA damage and the accumulation of cytosolic dsDNA, leading to the activation of the cGAS- and IFI16-dependent STING pathway in lung adenocarcinoma cells. IFN-γ-induced iNOS expression and nitric oxide production were responsible for DNA damage and STING activation. Additional etoposide treatment enhanced IFN-γ-induced IFN-β and CCL5 expression. Tumor-infiltrating T cells stimulated with a combination of anti-CD3 and anti-PD-1 antibodies caused STING activation and increased IFN-β and CCL5 expression in lung adenocarcinoma. These effects were abrogated by the addition of an IFN-γ neutralizing antibody. Our results suggest that the activation of tumor-infiltrating T cells could alter the tumor microenvironment via the IFN-γ-mediated activation of STING signaling in cancer cells.Entities:
Keywords: DNA damage; IFN-γ; STING; T cell activation; lung adenocarcinoma
Mesh:
Substances:
Year: 2022 PMID: 35273829 PMCID: PMC8903773 DOI: 10.1080/2162402X.2022.2044103
Source DB: PubMed Journal: Oncoimmunology ISSN: 2162-4011 Impact factor: 8.110